Product Dossier
RELISTOR
Product Dossier for RELISTOR (methylnaltrexone bromide, Link Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Link Pharmaceuticals
- Active ingredient: methylnaltrexone bromide
- Therapeutic area: Gastroenterology
- Same area: SALOFALK
- Same area: COLOFAC
What it is
Relistor is a methylnaltrexone bromide 12 mg/0.6 mL solution for injection.
Regulatory history
Relistor was first listed on the ARTG on 17 November 2008.